BVS Bioventus Inc.
$14.65▲ +1.60%
Healthcare
Other
After hours
$14.54▼ -0.73%
Oct 28, 4:46 PM ET
Volume 590.1K
Avg Volume (10D) 402.7K
Key Metrics & Fundamentals
Market Cap
$1.00B
P/E Ratio
18.8
Div Yield
0.00%
52W Range
6.47 - 15.89
% vs 50 MA
6.77%
% vs 200 MA
35.18%
RSI-14
60.0
MACD Histogram
+0.1300
Beta (1Y vs SPY)
0.59
Free Cash Flow
$18.91M
Gross Rev
$153.21M
Gross Profit
$105.67M
EBITDA
$29.91M
COGS
$47.54M
Operating Exp
$86.95M
Operating Income
$18.71M
EBIT
$18.71M
Pretax Income
$15.31M
Net Income
$33.44M
EPS (Diluted)
0.47
Price & Volume History
Loading chart…
Recent News
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026
GlobeNewswire · Oct 27, 2026 7:00 AM ET
Are Medical Stocks Lagging Bioventus (BVS) This Year?
Zacks · Aug 24, 2026 9:40 AM ET
4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike
Zacks · Aug 20, 2026 8:46 AM ET
Bioventus (BVS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 9:17 AM ET
Bioventus (BVS) Stock Still Looks Like A Bargain On Earnings
Simply Wall St. · Aug 10, 2026 4:10 PM ET
The Bull Case For Bioventus (BVS) Could Change Following Its Q2 Earnings Surge And Reaffirmed 2026 Guidance
Simply Wall St. · Aug 10, 2026 3:10 AM ET
Is Bioventus (BVS) Stock Undervalued Right Now?
Zacks · Aug 7, 2026 9:40 AM ET
Barrington Adjusts Price Target on Bioventus to $18 From $14, Maintains Outperform Rating
MT Newswires · Aug 6, 2026 9:32 AM ET
Bioventus Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 8:30 AM ET
Bioventus Inc (BVS) (Q2 2026) Earnings Call Highlights: Strategic Review and Strong HA Growth ...
GuruFocus.com · Aug 5, 2026 5:03 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BVS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.